Tag Archives: Cardioxyl Pharmaceuticals

November, 2015

  • 2 November

    Bristol-Myers Squibb to Acquire Biotech Cardioxyl Pharmaceuticals

    NEW YORK & CHAPEL HILL, N.C.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) and Cardioxyl Pharmaceuticals, Inc. announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the issued and outstanding capital stock of Cardioxyl, a private biotechnology company focused on the discovery and development …